We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Global Healthcare’s Three Big Forecasts: mHealth, Cloud Healthcare, and Regulator Environments

By LabMedica International staff writers
Posted on 09 Dec 2013
A new market research report, based on a 2013 growth survey, identified major areas of eHealth technology and integration with other businesses. More...


Frost & Sullivan (Mountain View, CA, USA), an international growth consultancy company, reported in December 2013 its three big predictions for the global healthcare market. Based on a “2013 Search for Growth” survey, which involved 1,835 executives in more than 40 countries worldwide, Frost & Sullivan’s insight highlighted new fields of growth and stated that mHealth (mobile health), the cloud in healthcare, and regulatory environments will be the major themes in 2014 and beyond.

“Frost & Sullivan’s research team has used the findings to select and prioritize the subjects that are deemed to be poised for the greatest growth,” explained Frost & Sullivan partner Dorman Followwill. “The insight has also been essential in unveiling the business outlook for pharmaceuticals, biotechnology, clinical diagnostics, and medical devices, as well as to provide a global perspective on the industry’s geographic hot spots.

mHealth expansion has been fuelled by the unprecedented spread of mobile technologies, as well as further developments in their novel application to address health priorities. It is mostly supported by mobile devices, such as mobile phones, patient monitoring devices, personal digital assistants (PDAs) and other wireless devices. The penetration outlook of mHealth technologies is significant in the following areas: wireless vital signs monitoring, location-aware telemonitoring systems, and Bluetooth wireless technology-enabled health trackers. It is a promising area of opportunity for healthcare growth and it will provide novel systems for participants and for both providers and patients across the spectrum.

Furthermore, as more healthcare information technology (IT) and patient monitoring tools are incorporated, every hospital facility will ultimately have to acquire a fully-enterprise wireless solution. The most innovative mobile healthcare solutions that best meet pressing healthcare needs will be adopted as the gold standard.

Enterprise-wide healthcare informatics will also improve the quality of medical services and efficiency of operations while slashing costs. Cloud computing is considered to be an essential enabler for enterprise-wide systems. Implementing cloud computing technologies correctly will help healthcare providers improve the quality of medical services and the effectiveness of operations, share data across geographic locations, and manage costs. The model can be applied in a range of ways, including data storage and data loss prevention, maintaining patient information records and authorized sharing of information.

The benefits that cloud computing provide can change the dynamics of the healthcare informatics industry over time. The need for efficient sharing of information across locations in a synchronized way will be a key driver for cloud computing in healthcare.

As for regulatory environment, recent healthcare reforms and policy initiatives across many countries have stressed the importance of quality of care more than quantity. In the absence of a sufficient proof of clinical benefit, reimbursements may become a major obstacle.

Overall, three big predictions may be expressed based on the survey’s findings: (1) as healthcare moves towards a customized medicine model, companion diagnostics will change drug development and the marketing process of drug candidates. Combining biomarkers and drugs will result in enhanced therapeutic efficacy and safety. (2) The healthcare and life sciences industry will additionally consolidate in this decade, with many big pharma companies looking for alternatives to the blockbuster model. (3) Lastly, the increase of new technologies capable of integrating medical devices into a connected platform will enhance the functionality of devices, decrease labor burden, and curtail errors.

Other significant areas that have emerged from the same survey include cancer market outlook, remote monitoring, drug delivery market, patient and consumer engagement, eHealth medical records, dashboards, medical devices growth drivers, drug discovery research outsourcing market, homecare market trends, video telemedicine, and cardiovascular therapeutics.

Frost & Sullivan collaborates with clients to utilize recent developments that addresses the global challenges and related growth opportunities that will make or break today’s market participants.

Related Links:

Frost & Sullivan



Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Giardia Assay
AccuDiag Giardia
New
Glucose Tolerance Test
NERL Trutol
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The tip optofluidic immunoassay platform enables rapid, multiplexed antibody profiling using only 1 μL of fingertip blood (Photo courtesy of hLife, DOI:10.1016/j.hlife.2025.04.005)

POC Diagnostic Platform Performs Immune Analysis Using One Drop of Fingertip Blood

As new COVID-19 variants continue to emerge and individuals accumulate complex histories of vaccination and infection, there is an urgent need for diagnostic tools that can quickly and accurately assess... Read more

Pathology

view channel
Image: Microscopy image of invasive breast cancer cells degrading their underlying extracellular matrix (Photo courtesy of University of Turku)

Visualization Tool Illuminates Breast Cancer Cell Migration to Suggest New Treatment Avenues

Patients with breast cancer who progress from ductal carcinoma in situ (DCIS) to invasive ductal carcinoma (IDC) face a significantly worse prognosis, as metastatic disease remains incurable.... Read more

Technology

view channel
Image: The machine learning-based method delivers near-perfect survival estimates for PAC patients (Photo courtesy of Shutterstock)

AI Method Predicts Overall Survival Rate of Prostate Cancer Patients

Prostate adenocarcinoma (PAC) accounts for 99% of prostate cancer diagnoses and is the second most common cancer in men globally after skin cancer. With more than 3.3 million men in the United States diagnosed... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.